Professional Documents
Culture Documents
Dental Treatment For The Handicapped & Medically Compromised Patient
Dental Treatment For The Handicapped & Medically Compromised Patient
• Osseous Disorders -
Rickets/osteoporosis
Agerholm (1975)
– Intrinsic – one from which person cannot
be separated.
– Extrinsic – one from which patient can be
separated eg: social deprivation.
Dental Diseases and Handicapped
Patients
• Poor oral hygiene and increase prevalence
of periodontal disease .
INTERESTE PARENT/
D PARTY RELATIVE
• 1 Patient Assessment past Dental, Medical
History and Clinical Examination
• POSITIONING
• a. Standing:- With a larger child, may stand
behind the child and cradle the patients head in
one arm, holding the lower jaw open with the
same hand while brushing / flossing with the
others.
– Mouth props can be used to avoid injury to
the caregiver
• b. Sofa: - sitting on a sofa and having the
patient lie with his head in the caretakers lap.
• c. Lap:- Toddler/small child can often be
easily handled with parent sitting on a chair
without arms. The child is placed across the
parent’s lap with the head hanging down
over one leg slightly to assist in opening
the mouth.
Vocabulary and
language skills
Mild to moderate
Traina such that child
54- Sedation, restrain
Moderate 51-36 ble MR can
40 to,+ve
(TMR) communicate at
reinforcement, GA
a basic level
with others
• Macroglossia- relative/absolute/fissured.
• Enlarged circumvallate papillae/ filiform
papillae absent
• Lips: thick /dry/fissured
• Poor anterior oral seal/ tongue thrust
• Small maxilla/ enlarged mandible: cl 3
• Cleft lip/palate/bifid uvula/high palate with
horizontal shelves
• Delayed eruption/ vary in shape /hypoplasia
• Congenital absence of teeth
Dental management
• Learning disability
• Co-operative
• LA / Sedation
• GA : difficulty in intubation due to hypoplastic
midface/respiratory disease:
• Cardiac defects: IE
• Possible atlanto- axial subluxation
• Hep B carriage
• Severe early onset pdl disease
• Defective cell mediated & humoral
immunity: defective phagocytic system
• PREVENTIVE MEASURES
AUTISM
• 3.4 every 1,000 children ages 3-10
• Speech impairment
Ataxic Cerebral Palsy
• very shaky or unsteady movements
• Disturbances in equilibrium –
stumbling/staggering gait / difficulty in
grasping objects
• Treatment – gingivectomy
– Meticulous oral hygiene is recommended to
prevent recurrence of hyperplasia
Type of first choice 2nd choice drug
epilepsy drug
• Unknown aetiology
• Congenital rubella/CMV
• Down syndrome
Congenital heart disorders
Cyanotic Acyanotic
Transposition of great VSD
vessels
Tetralogy of Fallot ASD
Eisenmenger’s syndrome PDA
Tricuspid atresia Aortic stenosis
Pulmonary atresia Coarcation of aorta
Acyanotic heart disorders
• Left to right shunting of blood
• VSD/ASD
• Hypoxia
• Poor development
• Heart murmurs
.
• the pulmonary artery
originates from the left
ventricle, so that most of
the blood returning from
the lungs goes back to the
lungs again
TETRALOGY OF FALLOT
• ventricular septal defect, that allows blood to pass
from the right ventricle to the left ventricle without
going through the lungs.
• a narrowing (stenosis) at or just beneath the
pulmonary valve that partially blocks the flow of
blood from the right side of the heart to the lungs.
• the right ventricle is more muscular than normal .
• the aorta lies directly over the ventricular septal
defect.
Coarcation of aorta
• the aorta is narrowed or constricted,
obstructing blood flow to the lower part of the
body and increasing blood pressure above the
constriction.
• no symptoms at birth, but they can develop as
early as the first week after birth.
• If severe symptoms of high blood pressure and
congestive heart failure develop, surgery may
be considered
Dental Management
• Medical History / consultation with child’s
cardiologist is a must.
• Antibiotic prophylaxis required for those
procedures likely to induce gingival bleeding. I
& D, scaling, intraligamentary injection,
orthodontic band placement require antibiotic
prophylaxis.
• Prophylaxis not required for: Removable
orthodontic appliances, fillings above the gum
line LA injection.
• Pulp therapy of primary teeth is not
recommended, extraction and space
maintainers are preferred
• In permanent teeth – endodontic therapy
after careful case selection may be done.
• Oral sedation and N2O analgesia may be
beneficial in decreasing anxiety.
• Patients on anticoagulant therapy require
hematological monitoring and cessation of
anticoagulant therapy before dental
treatment
Acquired heart disorders
Rheumatic fever
• Inflammatory disease as a delayed sequelae
to pharyngeal infection with group A
streptococci.( beta –hemolytic str/ Str.
Pyogenes)
• Infection can involve heart, joints, skin,
CNS, subcutaneous tissue
• 6-15 yrs
• Carditis in 50% of patients
Clinical features/diagnostic criteria
MAJOR MINOR
Carditis pyrexia
polyarthritis arthralgia
Syndhem’s Chorea/St Previous rheumatic fever
Vitus dance
Erythema marginatum ESR & C reactive Protein
raised
Subcutaneous nodules
• Subendocardial inflammation along the lines of
closure of mitral & aortic valve cusps leading
to minute fibrinous vegetations & scarring.
• IE/ CHF
Dental management
• Risk of IE in cases of rheumatic carditis
• ANTIBIOTIC PROPHYLAXIS
Infective Bacterial Endocarditis
• Microbial infection of heart valves/
endocardium in proximity to congenital /
acquired cardiac defects.
• Embolization
• Irregular fever ( afternoon/nights)
• Sweating, malaise, anorexia, weight loss,
arthralgia
• Painful fingers, toes, skin lesions
Endocarditis Prophylactic Regimens for Dental, Oral,
Respiratory Tract, and Esophageal Procedures
Adults: 2 g; children
or 50 mg/kg
Cefadroxil2 or orally 1 h before
cephalexin2 procedure
or Cefazolin2
Adults: 1.0 g; children 25
mg/kg IM or IV within 30
min before procedure
HEMORRHAGIC DISORDERS
• Platelet / Vascular disorders :characterized by
purpura, i.e. by superficial bleeding with
formation of petechiae and echymosis.
• DIAGNOSIS –
• Prolonged APTT (activated plasma
thromboplastin time)
• Decreased factor VIII
• Normal PT
• Normal BT
Management
• Mainstay of therapy – purified concentrate of
the missing factor, extracted from blood
plasma. Life of factor VIII is low, only around
12 hours.
• Use of desmopressin acetate: - IV in mild
hemophiliacs
• Increases factor VIII activity to 300 – 400%
2 hrs after infusion of 0.3 – 0.4 mg/kg body
weight. It induces release of factor VIII that is
normally bound to vascular basement
membrane.
• Σ aminocaproic acid (EACA) used as an
adjunct with factor therapy.
• normal fibrinolytic mechanism but generation
of thrombin necessary for clot formation is
either inadequate/retarded .Loose friable clots
are formed which are easily dislodged. The
fibrinolytic mechanism is effectively inhibited
by EACA allowing more stable clot to form
and retract.
• hypotension / nausea and vomiting.
• replaced by tranexamic acid which is 10 times
more patient than EACA.
Complication
• 5-20% of hemophiliacs develop inhibitory
antibodies :bleeding episodes are more difficult
to control.
• patients with low titer, effect may be overcome
by high doses of concentrate.
• high titer, effects of inhibitors may be
bypassed through the use of prothrombin
complex concentrate / DDAVP (1- deamino-8
dearginine vasopressin)
• Risk of HIV and Hepatitis B Infection. –
Heat treatment of pooled donor factor
eliminates infectivity of both HIV and
Hepatitis B.
Dental treatment
• Relief of anxiety : important ;direct
relationship between anxiety and
antifibrinolytic activity
• - N2O – O2 inhalational analgesia /
Hypnosis can be beneficial
• - I.M. injection of hypnotics /
tranquilizers are contraindicated due to risk of
hematoma formation.
• . Intraligamentary injections can be safely used
in the absence of factors replacement.
• Generalized lymphadenopathy
• Generalized dermatitis